Company news

Anteris Technologies Global Corp. news in 2026

Anteris Technologies Global Corp.'s news releases, calls and decks from 2026, newest first.

View company

Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026

November 1, 2026

Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026

October 27, 2026

Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance

October 19, 2026

Anteris to Present at September Healthcare Investor Conferences

August 31, 2026

Anteris Technologies Announces Results for the Second Quarter of 2026

August 11, 2026

Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

June 8, 2026

Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors

May 13, 2026

Anteris Announces Results for the First Quarter of 2026

May 12, 2026

Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial

May 5, 2026

Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial

April 28, 2026

Anteris Reports 2025 Financial Results and Provides Corporate Update

February 25, 2026

Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays

February 23, 2026

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

January 22, 2026

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

January 22, 2026

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

January 20, 2026

Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic

January 20, 2026

Decks in 2026